Christopher Foley

895 total citations
18 papers, 588 citations indexed

About

Christopher Foley is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Foley has authored 18 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Foley's work include Chemical Synthesis and Analysis (4 papers), Ubiquitin and proteasome pathways (4 papers) and Multicomponent Synthesis of Heterocycles (4 papers). Christopher Foley is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Ubiquitin and proteasome pathways (4 papers) and Multicomponent Synthesis of Heterocycles (4 papers). Christopher Foley collaborates with scholars based in United States, Netherlands and Italy. Christopher Foley's co-authors include Christopher Hulme, Nicholas Mitsiades, Arthur Y. Shaw, Cristian Coarfa, Kimal Rajapakshe, Shrijal S. Shah, Warren Fiskus, John Shou, Chuandong Geng and Travis Dunckley and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Christopher Foley

18 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Foley United States 13 311 150 134 97 68 18 588
John A. Mitchell United States 10 404 1.3× 37 0.2× 75 0.6× 67 0.7× 177 2.6× 18 777
Shinmee Mah South Korea 9 369 1.2× 79 0.5× 136 1.0× 41 0.4× 15 0.2× 13 597
Charles W. Chapman United States 10 288 0.9× 109 0.7× 78 0.6× 21 0.2× 22 0.3× 16 502
Francesco Sirci Italy 12 327 1.1× 83 0.6× 35 0.3× 23 0.2× 26 0.4× 17 511
Catherine Magill United States 7 153 0.5× 91 0.6× 76 0.6× 89 0.9× 19 0.3× 10 397
Marco Rosetti Italy 14 240 0.8× 88 0.6× 34 0.3× 100 1.0× 42 0.6× 28 486
Christine Orr Canada 10 569 1.8× 54 0.4× 47 0.4× 63 0.6× 20 0.3× 15 836
Martine Duval Canada 7 215 0.7× 29 0.2× 24 0.2× 55 0.6× 54 0.8× 15 427
Dorien Clarisse Belgium 12 201 0.6× 24 0.2× 79 0.6× 37 0.4× 123 1.8× 25 487
Joanna Kałafut Poland 11 329 1.1× 30 0.2× 44 0.3× 110 1.1× 35 0.5× 27 498

Countries citing papers authored by Christopher Foley

Since Specialization
Citations

This map shows the geographic impact of Christopher Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Foley more than expected).

Fields of papers citing papers by Christopher Foley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Foley. The network helps show where Christopher Foley may publish in the future.

Co-authorship network of co-authors of Christopher Foley

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Foley. A scholar is included among the top collaborators of Christopher Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Foley. Christopher Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Foley, Christopher, Breland E. Smith, Aaron Babendreyer, et al.. (2024). Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B. Journal of Medicinal Chemistry. 67(19). 17259–17289. 6 indexed citations
2.
Zhu, Bangfu, et al.. (2022). DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity. Scientific Reports. 12(1). 15847–15847. 10 indexed citations
3.
Townsend, Julia A., et al.. (2021). Suzuki Coupling of Protected Aryl Diazonium Ions: Expanding the Knowledge of Triazabutadiene Compatible Reactions. Organic Letters. 23(5). 1851–1855. 4 indexed citations
4.
Gunawan, Steven, et al.. (2021). Oxidations of pyrrolidines and piperidines to afford CH-functionalized isopropyl-1-carboxylate congeners. Tetrahedron Letters. 69. 152978–152978. 1 indexed citations
6.
Foley, Christopher, et al.. (2020). 5-Endo Trig Oxidative Radical Cyclizations of Ugi-3CR Products toward 1,4-Imidazolidinones. Organic Letters. 23(1). 107–112. 12 indexed citations
7.
Velázquez, Ramón, Bessie Meechoovet, Christopher Foley, et al.. (2019). Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice. Molecular Neurobiology. 56(12). 8364–8375. 30 indexed citations
8.
Zhang, Jiantao, Yanmei Hu, Christopher Foley, et al.. (2018). Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance. Scientific Reports. 8(1). 4653–4653. 31 indexed citations
10.
Foley, Christopher, et al.. (2017). Copper(i) catalyzed oxidative hydrolysis of Ugi 3-component and Ugi-azide reaction products towards 2° α-ketoamides and α-ketotetrazoles. Organic & Biomolecular Chemistry. 15(29). 6132–6135. 16 indexed citations
11.
Geng, Chong, Salma Kaochar, Kimal Rajapakshe, et al.. (2017). SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein. Oncogene. 36(33). 4767–4777. 88 indexed citations
12.
Foley, Christopher, Arthur Y. Shaw, & Christopher Hulme. (2017). Oxidative Deaminations and Deisatinylations of Ugi-Azide and Ugi-3CR Products: A Two-Step MCR-Oxidation Protocol toward Functionalized α-Ketoamides and α-Ketotetrazoles. Organic Letters. 19(9). 2238–2241. 13 indexed citations
13.
Branca, Caterina, Ramona Belfiore, Vijay Gokhale, et al.. (2017). Dyrk1 inhibition improves Alzheimer's disease‐like pathology. Aging Cell. 16(5). 1146–1154. 87 indexed citations
14.
Foley, Christopher, et al.. (2017). Synthesis of fluorescent heterocycles via a Knoevenagel/[4 + 1]-cycloaddition cascade using acetyl cyanide. Organic & Biomolecular Chemistry. 15(29). 6076–6079. 19 indexed citations
15.
Foley, Christopher & Nicholas Mitsiades. (2016). Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer. Hormones and Cancer. 7(2). 84–103. 48 indexed citations
16.
Foley, Christopher, Arthur Y. Shaw, & Christopher Hulme. (2016). Two-Step Route to Diverse N-Functionalized Peptidomimetic-like Isatins through an Oxidation/Intramolecular Oxidative-Amidation Cascade of Ugi Azide and Ugi Three-Component Reaction Products. Organic Letters. 18(19). 4904–4907. 28 indexed citations
17.
Eedunuri, Vijay Kumar, Kimal Rajapakshe, Warren Fiskus, et al.. (2015). miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation. Molecular Endocrinology. 29(8). 1170–1183. 30 indexed citations
18.
Geng, Chuandong, Kimal Rajapakshe, Shrijal S. Shah, et al.. (2014). Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer. Cancer Research. 74(19). 5631–5643. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026